Отправлено 02 Май 2024 - 17:19
Buy Raloxifene, a medication primarily used to prevent and treat osteoporosis in postmenopausal women, carries certain risks that individuals should be aware of. One significant risk is the potential for blood clots, particularly deep vein thrombosis (DVT) and pulmonary embolism (PE). Therefore, individuals with a history of blood clots or clotting disorders should use raloxifene cautiously or avoid it altogether.
Another risk is an increased chance of developing hot flashes, leg cramps, and peripheral edema (swelling in the extremities). Raloxifene may also slightly elevate the risk of stroke, especially in women with pre-existing risk factors for stroke.
Additionally, there is a small but increased risk of developing endometrial cancer while taking raloxifene. Women with a history of uterine or endometrial cancer should avoid this medication.
Before starting raloxifene, discuss your medical history and any concerns with your healthcare provider to weigh the benefits and risks of treatment effectively. Regular monitoring and adherence to prescribed guidelines can help mitigate these risks.
